BLAINJECTIONINJECTABLE
Approved
Aug 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
7/8 — Comprehensive
GENOTROPIN (somatropin) by Pfizer is vitro, preclinical, and clinical tests have demonstrated that genotropin lyophilized powder is therapeutically equivalent to human growth hormone of pituitary origin and achieves similar pharmacokinetic profiles in normal adults. Approved for growth hormone deficiency, turner syndrome, small for gestational age and 1 more indications. First approved in 1995.
Drug data last refreshed 18h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GENOTROPIN (somatropin) is a recombinant human growth hormone injectable approved since 1995 that is therapeutically equivalent to pituitary-derived growth hormone. It is indicated for growth failure in pediatric patients with growth hormone deficiency, Prader-Willi syndrome, small for gestational age birth, Turner syndrome, and idiopathic short stature, as well as for adults with GHD to reduce fat mass and increase lean body mass. The drug works by stimulating linear growth and normalizing IGF-I concentrations, with demonstrated benefits in metabolic parameters including lipid metabolism. GENOTROPIN holds a significant market position in the somatropin class but faces substantial competitive pressure from multiple branded alternatives.
$0.0BPart D
Mechanism of Action
vitro, preclinical, and clinical tests have demonstrated that GENOTROPIN lyophilized powder is therapeutically equivalent to human growth hormone of pituitary origin and achieves similar pharmacokinetic profiles in normal adults. In pediatric patients who have growth hormone deficiency (GHD), have…
Indications (4)
Worked on GENOTROPIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.